Research programme: prophylactic malaria vaccines - Genocea Biosciences

Drug Profile

Research programme: prophylactic malaria vaccines - Genocea Biosciences

Alternative Names: GEN-005; T cell antigen malaria vaccine - Genocea Biosciences

Latest Information Update: 17 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genocea Biosciences
  • Developer Genocea Biosciences; Naval Medical Research Center
  • Class Parasitic vaccines; Protein-vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Research Malaria

Most Recent Events

  • 17 May 2018 Early research and development is ongoing in USA (Genocea Biosciences website, May 2018)
  • 17 May 2018 Research programme: prophylactic malaria vaccines - Genocea Biosciences is available for licensing as of 17 May 2018.
  • 01 Jan 2018 Genocea receives patent allowance for ATLAS platform in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top